|
J Biol Chem, Vol. 275, Issue 9, 6469-6478, March 3, 2000
Determination of the Disulfide Bond Arrangement of Newcastle
Disease Virus Hemagglutinin Neuraminidase
CORRELATION WITH A -SHEET PROPELLER STRUCTURAL FOLD PREDICTED
FOR Paramyxoviridae ATTACHMENT PROTEINS*,
James J.
Pitt,
Elizabeth
Da Silva, and
Jeffrey J.
Gorman
From the Biomolecular Research Institute, Parkville,
Victoria 3052, Australia
 |
ABSTRACT |
Disulfide bonds stabilize the structure and
functions of the hemagglutinin neuraminidase attachment glycoprotein
(HN) of Newcastle disease virus. Until this study, the disulfide
linkages of this HN and structurally similar attachment proteins of
other members of the paramyxoviridae family were undefined.
To define these linkages, disulfide-linked peptides were produced by
peptic digestion of purified HN ectodomains of the Queensland strain of
Newcastle disease virus, isolated by reverse phase high performance
liquid chromatography, and analyzed by mass spectrometry. Analysis of peptides containing a single disulfide bond revealed
Cys531-Cys542 and
Cys172-Cys196 linkages and that HN ectodomains
dimerize via Cys123. Another peptide, with a
chain containing Cys186 linked to a chain containing
Cys238, Cys247, and Cys251, was
cleaved at Met249 with cyanogen bromide. Subsequent tandem
mass spectrometry established Cys186-Cys247 and
Cys238-Cys251 linkages. A glycopeptide with a
chain containing Cys344 linked to a chain containing
Cys455, Cys461, and Cys465 was
treated sequentially with peptide-N-glycosidase F and
trypsin. Further treatment of this peptide by one round of manual Edman degradation or tandem mass spectrometry established
Cys344-Cys461 and
Cys455-Cys465 linkages. These data,
establishing the disulfide linkages of all thirteen cysteines of this
protein, are consistent with published predictions that the
paramyxoviridae HN forms a -propeller structural fold.
 |
INTRODUCTION |
Newcastle disease virus
(NDV)1 and mumps virus belong
to the rublavirus genus of the subfamily
paramyxovirinae within the paramyxoviridae family
of negative strand nonsegmented RNA viruses (1, 2). Rublaviruses are enveloped viruses with a lipid membrane
bilayer containing two integral membrane glycoproteins that mediate the process of invasion of host cells by the virus through the two steps of
attachment and fusion. Attachment is mediated by a type II integral
membrane protein with hemagglutinin and sialidase activities, termed
the hemagglutinin neuraminidase (HN). Fusion is caused principally by a
type I integral membrane protein, termed the fusion protein (3, 4).
There is evidence that the HN assists in the fusion process via
interaction(s) with the fusion protein (3, 5-8).
Other members of the paramyxoviridae have similar membrane
glycoproteins to orchestrate transmission of their nucleocapsids, containing their negative sense RNA genomes, into host cells. All
members of the paramyxoviridae have fusion proteins with
very similar structural motifs; however, the attachment proteins of the
different subfamilies and genera exhibit different functional profiles
and substantial structural variability. Members of the paramyxovirus genus (e.g. parainfluenza viruses)
also have HN proteins, and members of the morbillivirus
genus (e.g. measles virus) have a similar protein with
hemagglutinin (H) activity and little (9) or no (10) sialidase
activity. Whereas pneumovirus of mice exhibits hemagglutinin activity
(11, 12), other members of the pneumovirinae subfamily lack
both hemagglutinin and sialidase activities (13, 14), and their
attachment proteins are structurally distinct from the other
paramyxoviridae attachment proteins (15).
Influenza A and B viruses also exhibit the same functional
characteristics as members of the rublaviruses such as NDV
and paramyxoviruses such as the parainfluenza viruses (16).
However, the attachment and fusion activities of these influenza
viruses are associated with an H (17), and the sialidase activity is located on a separate protein, the neuraminidase (18).
Three-dimensional structures of the influenza neuraminidases have been
determined by x-ray crystallography (19-24). This structure has been
described as a -sheet propeller structure with the blades
representing -sheets connected by loops. The four -strands within
each of these sheets are also connected by loops and arranged in an
antiparallel fashion. No structure has been reported to date for any
paramyxoviridae attachment protein. Despite this, structural
predictions indicate that the HN has a three-dimensional fold similar
to influenza neuraminidases (9, 25-27).
The HN ectodomains of the different strains of NDV are comprised of
approximately 525 amino acids within which are usually twelve or
thirteen cysteine residues and five or six consensus sites for
N-linked glycosylation (28). A cysteine residue at position
123, which is variably present in different strains (28) of the virus,
is believed to form an intermolecular disulfide with another HN
ectodomain to form a covalent homodimer (29-32). There is evidence
that the HN exists as a tetramer on virions (29, 32-34) but the
association of covalent homodimers into homotetramers does not appear
to rely on formation of additional covalent bonds (34). Predicted
folding of the HN has suggested possible pairings between the remaining
cysteines (9, 26, 27). Cysteine mutagenesis studies (31) have provided
some experimental support for these predictions; however, the complete
disulfide bond pattern of the protein has not been determined experimentally.
This report describes isolation of NDV HN ectodomains, generation and
isolation of disulfide-linked peptides from the HN, and a comprehensive
mass spectrometric analysis of the disulfide linkages between and
within these peptides. The experimentally determined complete disulfide
bond arrangement of the NDV HN is reported herein and compared with the
disulfide bond patterns predicted by previous molecular modeling and
cysteine mutagenesis studies.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Dispase grade I (a neutral protease from
Bacillus polymyxa), n-octylglucoside, pepsin,
peptide-N-glycosidase F (PNGase F), trypsin and chymotrypsin
were from Roche Molecular Biochemicals. Tributylphosphine was from
Tokyo Kasei and tris-(2-carboxyethyl)phosphine (TCEP) and
cyanogen bromide were from Pierce.
2'-(4-Methylumbelliferyl)- -D-N-acetyl-neuraminic acid (MUNANA) was from Sigma. A vaccine preparation of the V4 isolate
of the Queensland strain of NDV was obtained from Arthur Webster Pty.
Ltd., Northmead, New South Wales, Australia. 2,6-Dihydroxyacetophenone from Fluka was recrystallized from 20% (v/v) ethanol while
-cyano-4-hydroxy cinnamic acid from Aldrich was recrystallized from
methanol. All other reagents were of either reverse-phase high
performance liquid chromatography (RP-HPLC) grade or the highest
quality analytical reagent grade.
Isolation of NDV HN Ectodomain Dimers--
NDV was propagated in
10-day-old embryonated chicken eggs and harvested as described
previously (35, 36). The final pellet of virions was suspended to a
concentration of approximately 10 mg/ml in 10 mM HEPES, 100 mM NaCl, 1 mM EDTA (HNE) buffer (pH 7.2). An
equal volume of 4% (w/v) n-octylglucoside in
H2O was added to the virus preparation, and the mixture was
allowed to stand at 22 °C for 30 min. Released nucleocapsids and any
insoluble membrane aggregates were removed by centrifugation for
1.5 h at 110,000 × g and 15 °C. Dispase (10 mg/ml in HNE buffer (pH 7.2)) and CaCl2 were added to the
separated supernatant of the detergent-solubilized virions to final
concentrations of 50 µg/ml and 10 mM, respectively. Dispase digestion was then conducted for 2 h at 37 °C, and the digest was cooled to 4 °C prior to adding 10 volumes of
n-butanol at 20 °C. The n-butanol and
aqueous phases were mixed gently until any signs of an emulsion
disappeared, and precipitation of proteins was allowed to proceed for
16 h at 20 °C. Precipitated protein was recovered by
centrifugation at 10 °C, washed twice with n-butanol at
20 °C and once with diethylether at 20 °C, and subsequently
dried under a stream of high purity nitrogen gas. The dried protein
preparation was resuspended in HNE buffer (pH 7.2), clarified by
centrifugation, and filtered through a 0.22 µM membrane
prior to application to a column of Superose 12 (Amersham Pharmacia
Biotech) (2.6 cm × 95 cm). Separation of the proteins was
achieved by elution at 2 ml/min and 22 °C with HNE buffer (pH 7.2)
containing 0.02% (w/v) sodium azide. The effluent was continuously
monitored at 280 nm for the presence of protein, and 5-ml fractions
were collected. Detection of sialidase activity in column fractions was
achieved by using MUNANA acid as a substrate. This involved incubation
of 5 µl of each fraction with 50 µl of a solution containing 85 µM MUNANA, 8.5 mM CaCl2, and 85 mM sodium cacodylate (pH 6.5). After incubation for 5 min
at 22 °C in the dark the reaction was terminated by the addition of
200 µl of 133 mM glycine, 33 mM
Na2CO3 (pH 10.7). Liberation of
methylumbelliferone as a consequence of sialidase activity was
determined by reading the resultant fluorescence in a Perkin-Elmer
LS50B fluorimeter fitted with a plate reader and set for excitation at
365 nm and emission at 450 nm. The fractions of apparent homogeneity by
polyacrylamide gel elctrophoresis in the presence of sodium dodecyl
sulfate (SDS-PAGE) (37) and highest specific sialidase activity were
pooled and concentrated at 4 °C to 10-12 mg/ml using an
Amicon-stirred cell fitted with a YM 10 membrane. Concentrated protein
preparations were stored at 4 °C.
Protein and Peptide Cleavages--
Pepsin digestion of HN
ectodomains was conducted on ~400 µg of HN after precipitation of
the protein from HNE buffer by the addition of 9 volumes of methanol at
20 °C and leaving the protein at 20 °C for 16 h. The
resultant pellet was collected by centrifugation at 4 °C, washed
with 20 °C methanol, and dried in vacuo. The dried
pellet was dissolved in 100 µl of 100 mM acetic acid, 100 mM formic acid and incubated at 37 °C for 3 h after
adding 20 µg of pepsin in 2 µl of 100 mM acetic acid,
100 mM formic acid.
PNGase F/trypsin digestion was performed after reconstitution of the
contents of dried RP-HPLC fractions in 20 µl of 100 mM ammonium bicarbonate containing 1 mM
N-ethylmaleimide, by the addition of 5 units of PNGase F and
incubation at 37 °C for 2 h. Subsequent tryptic cleavage was
achieved by the addition of 1 µg of trypsin and incubation at
37 °C for 24 h. Chymotryptic digestion was performed after
RP-HPLC fractions were dried in vacuo and reconstituted in
10 µl of 100 mM ammonium bicarbonate by the addition of
0.5 µg of chymotrypsin solution and incubation at 37 °C for 3 h.
Cyanogen bromide treatment was performed on RP-HPLC fractions that had
been dried in vacuo and reconstituted in 9 µl of 70% (v/v) trifluoroacetic acid. Cleavage was achieved by the addition of 1 µl of 1 M cyanogen bromide in acetonitrile and incubation at 22 °C for 13 h. The sample was evaporated in
vacuo, and residual cyanogen bromide was removed by three cycles
of reconstitution in 20 µl of 33% acetonitrile containing 0.1%
(v/v) trifluoroacetic acid and evaporation. Prior to further analysis
the sample was desalted on a microcolumn of C18 silica.
Manual Edman degradation was performed in 1-ml tapered Reactivials.
Dried samples were reconstituted in 20 µl of 50% (v/v) pyridine:water containing 1 mM N-ethylmaleimide;
5 µl of 50% (v/v) pyridine:water saturated with phenyl
isothiocyanate was added, and the mixture was incubated at 50 °C for
20 min under nitrogen. The aqueous phase was extracted twice with 400 µl of heptane:ethyl acetate 2:1 (v/v) and then dried in
vacuo. Cleavage was performed by adding 20 µl of trifluoroacetic
acid and heating at 50 °C for 7 min under nitrogen. Trifluoroacetic
acid was removed in vacuo, and the tube was washed with
diethyl ether. After drying the tube in vacuo the truncated
peptide was dissolved in 33% acetonitrile:water (v/v) containing 0.1%
trifluoroacetic acid for subsequent analysis.
RP-HPLC--
A Hewlett Packard 1090M system was used for
preparative RP-HPLC. Peptide separation was achieved at 0.15 ml/min
using a 2.1 mm × 25 cm C18 column (Vydac, catalog
number 218TP52) with a linear gradient from 0.1% (v/v) aqueous
trifluoroacetic acid to 32% (v/v) aqueous acetonitrile containing
0.1% (v/v) trifluoroacetic acid over 60 min and a subsequent linear
increase in the acetonitrile concentration to 80% (v/v) over 20 min. A
HP1090 photodiode array detector was used to continuously monitor the
eluant at 214 and 280 nm. Fractions were collected into polypropylene
tubes for subsequent analysis. Where required, peptic digests were
reduced prior to RP-HPLC by the addition of 6 µl of 1 M
ammonium bicarbonate to 30 µl of the digest, followed by 5 µl of
1% (v/v) tributylphosphine in isopropanol. The mixture was incubated
at 37 °C for 45 min and then evaporated to dryness in
vacuo. Traces of tributylphosphine were removed by two cycles of
adding 20 µl of isopropanol and re-evaporation. The reduced digest
was reconstituted in 50 µl of 0.2% (v/v) trifluoroacetic acid.
Matrix-assisted Laser Desorption/Ionization-Time-of-Flight-Mass
Spectrometry (MALDI-TOF-MS)--
Protein molecular weight
determination was performed in linear mode using a Bruker Reflex
time-of-flight instrument fitted with a 337-nm nitrogen laser. Samples
were ionized from a matrix comprised of 2,6-dihydroxyacetophenone
containing diammonium hydrogen citrate (38), and bovine serum albumin
was used for external calibration. Protein ions were accelerated at 20 kV and detected with a Bruker HIMAS detector. Peptides were analyzed in
reflector mode with delayed extraction using an acceleration voltage of 20.0 kV and a reflectron voltage of 22.8 kV. Peptide data were generally collected after ionization from the above matrix at 500 MHz
in the m/z = 500 to 8000 range with the instrument
calibrated externally using a mixture of human angiotensin II, ACTH
clip (residues 18-39), and bovine insulin. Peptide sequencing by
post-source decay (PSD) employed an acceleration voltage of 26.3 kV and
a series of 14 reflectron voltage steps from 30 to 0.95 kV. Individual spectra were obtained at each step by collecting ~50-100 laser shots. A pulsed gate mounted shortly after the ion source was used to
select precursor ions. Bruker XMASS software was used to assemble
resulting spectra onto a continuous true m/z scale. PSD
spectra were calibrated using a calibration file created with fragments
of ACTH residues 18-39 (39).
Reduction of disulfide-linked peptides prior to MALDI-TOF-MS was
performed by mixing 4 µl of digest or RP-HPLC fraction with 0.5 µl
of 1 M diammonium hydrogen citrate and 0.5 µl of 50 mM TCEP and incubation of the mixture at 37 °C for 60 min (38). For molecular weight determination of the reduced peptides, 1 µl of the reduction mixture was mixed with 1 µl of
2,6-dihydroxyacetophenone solution (10 mg/ml in 1:1
ethanol:acetonitrile (v/v)), and 1 µl of this mixture was dried
briefly in vacuo on a stainless steel sample target. For PSD
analysis of reduced peptides, 0.5 µl of the reduction mixture was
mixed with 0.5 µl of 5% (v/v) trifluoroacetic acid, placed on a
preprepared thin layer of -cyano-4-hydroxy cinnamic acid (40), and
dried briefly in vacuo. The sample spot was then washed with
two 1-µl aliquots of 1% (v/v) trifluoroacetic acid saturated with
-cyano-4-hydroxy cinnamic acid, excess solvent being removed with a
stream of nitrogen.
Electrospray Ionization-Mass Spectrometry (ESI-MS)--
A
Hewlett Packard 1100 system was used for liquid chromatography-MS with
separation performed on a 1 mm × 25 cm C18 column (Vydac, catalog number 218TP51) at a flow rate of 40 µl/min using the
same gradient as was used for preparative RP-HPLC except the initial
and final trifluoroacetic acid concentrations were 0.05 and 0.045%
(v/v), respectively. A HP 1100 photodiode array detector was used to
continuously monitor the absorbance of the eluate at 214 and 280 nm,
and the outlet of the flow cell was connected directly to the ESI
source of a PE-Sciex 150EX liquid chromatography-MS system via a short
length of fused silica tubing. The mass spectrometer was scanned from
m/z = 100 to 3000 with an ion source orifice potential
of 50 V. For experiments involving the production of in-source
collisional fragmentation an orifice potential of 80 V was used. The
mass spectrometer was scanned with a 0.25 atomic mass unit step and a
dwell time of 0.40 or 0.50 ms/step.
Tandem mass spectrometry (MS/MS) experiments were performed using a
PE-Sciex API-300 system. Samples, in a solvent of 50% (v/v)
acetonitrile containing 0.1% (v/v) formic acid were continuously infused into the ion source via a Micro-ion Spray interface at a flow
rate of 12 µl/hour maintained with a Harvard Model 55-1111 syringe
pump. Precursor ions were selected at a resolution of 0.6 Da and
fragmented by collision with nitrogen at an energy of 60 or 40 eV. Data
were accumulated and averaged over a period of ~15 min.
N-terminal Sequence Analysis--
Automated Edman degradation
was performed using a Hewlett Packard 241 (N + C) protein sequenator.
Nomenclature--
Disulfide linkages are indicated by slashes as
follows: Cysm/Cysn indicates linkage of a
peptide containing cysteine residue m in the protein sequence to a
peptide containing cysteine residue n;
Cysw/(Cysx, Cysy,
Cysz/) indicates that a peptide containing cysteine residue
w is linked to a peptide containing cysteines x, y, and z, which
contains an additional intrachain disulfide;
Cysw/(Cysx,Cysy)/Cysz
indicates that separate peptides containing cysteines w and z, respectively, are linked to a peptide containing cysteines x and y but
the linkage pattern is not defined; Cysw/Cysx,
Cysy/Cysz indicates that a peptide containing
cysteine residue w is linked via cysteine x to a peptide containing
cysteines x and y which, is in turn linked to another peptide by
linkage between cysteines y and z. Similarly,
Xaaj-Xaak/Xaap-Xaaq
describes a disulfide linkage between a peptide segment encompassing amino acid residues j to k and a peptide segment encompassing amino
acid residues p to q and
Xaaa-Xaab/Xaac-Xaad/Xaae-Xaaf
indicates that peptide segments encompassing residues a to b and e to
f, respectively, are linked by disulfide bonds to a peptide segment
encompassing residues c to d.
 |
RESULTS |
Characterization of the Membrane Anchor-free NDV HN--
The
supernatants from high speed centrifugation of detergent-solubilized
NDV preparations showed a major Coomassie Blue staining component of 71 kDa upon SDS-PAGE under reducing conditions (Fig. 1A, lane 1). This
component appeared to be converted to a band of 63 kDa upon exposure to
Dispase (Fig. 1A, lane 2). Analysis of fractions
produced by chromatographic separation of the Dispase-treated detergent
extract on Superose 12 revealed that the majority of the sialidase
activity was evident in a symmetrical peak with maximal absorbance in
fraction 51 (Fig. 1B). A trace of sialidase activity
co-eluted with a peak of absorbance in the void volume of the column.
The major sialidase activity peak also contained the 63-kDa product of
Dispase cleavage (Fig. 1A, lane 4). Selection of
fractions 48-54 to pool for further processing was based on homogeneity estimations by SDS-PAGE gels and sialidase activity of
individual fractions.

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 1.
Isolation and characterization of soluble HN
ectodomains. A, SDS-PAGE analysis (12% gels) of:
lanes 1 and 2, high speed supernatant of
detergent-solubilized NDV (10 µg) before and after Dispase treatment,
respectively; and, lanes 3 and 4, 2.5 µg of
nonreduced and reduced protein, respectively, from pooled fractions of
Superose 12 eluate (B) that exhibited maximal neuraminidase
activity. Lanes marked M indicate calibration mixtures
containing proteins with the molecular mass to the left of
each panel. M1 denotes Bio-Rad molecular weight markers
dissolved in reducing sample buffer and M2 denotes Novex
prestained markers dissolved in nonreducing sample buffer.
B, Superose 12 chromatogram of Dispase-treated high speed
supernatant of detergent-solubilized NDV. The protein was precipitated
from 100 ml of treated supernatant with n-butanol, processed
further, and applied to the column in 10 ml of buffer as described
under "Experimental Procedures." The shaded area
indicates fractions 48-54 that exhibited maximal neuraminidase
activity and were pooled for further characterization.
|
|
N-terminal sequence analysis of the protein present in the pooled peak
of sialidase activity from the Superose 12 column indicated that
Dispase cleavage produced soluble HN ectodomains with ragged N termini
corresponding to Ala117, Ala118, or
Ser119 of the untruncated protein sequence (Fig.
2A). This finding indicates that an asparagine usually found at position 119 (28) was a serine in
the isolate of NDV used in this study. SDS-PAGE analysis of the
nonreduced protein revealed a molecular weight consistent with
disulfide linkage of two monomers (Fig. 1A, lane
3). MALDI-TOF-MS of the product showed a broad base peak of
m/z = 113,000 and a smaller peak at m/z = 56,615 consistent with the doubly charged version of this ion
(supplemental Fig. S1). These data are also consistent with disulfide
linkage of two truncated NDV HN ectodomains. Assuming that Dispase did
not cleave the C terminus of the ectodomains, these data also indicate
that glycosylation contributes approximately 12,700 Da to the mass of
the dimer.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 2.
Sequence and topological model of the
ectodomain of NDV HN showing experimentally determined disulfide
linkages. A, sequence of the ectodomain of the
Queensland strain of NDV HN. Two amino acid variations were detected in
the ectodomain of the isolate of the virus used in this study compared
with those published for the Queensland strain ((44), Swiss Prot
accession number P13850, GenBankTM accession number J03911)
namely N119S and I175M. Glycosylated N-linked consensus
sites have solid underlines, whereas an unoccupied site at
Asn538 has a dashed underline. Sites of Dispase
cleavage to release soluble ectodomain heads are indicated by
upward arrows. The major sites of cleavage by pepsin to
produce disulfide-linked peptides used to define disulfide linkages are
indicated by downward arrows. Dashed arrows
indicate minor peptic cleavage sites. Disulfide bond linkages are
indicated by bold lines. B, experimentally
determined disulfide bonds are shown as bold lines linking
structural units within a proposed model of HN. Demarcation of the
sequence segments forming -stands of the six -sheets, labeled
1- 6, short loops joining the strands in an antiparallel manner
and longer loops connecting each sheet is based on the model of
Langedijk et al. (9). The experimentally determined
disulfide linkages differ from those proposed in the theoretical model
in that the model had Cys344/Cys465 and
Cys455/Cys461 linkages.
|
|
Isolation of Disulfide-linked Peptides--
RP-HPLC of nonreduced
peptic digests of HN produced a chromatogram consisting of relatively
broad and incompletely resolved peaks (Fig.
3A). A chromatogram was also
obtained by reduction of the peptic digest before performing RP-HPLC
(Fig. 3B). Careful comparison of the RP-HPLC chromatograms
of the nonreduced and reduced samples revealed five major peaks in the
nonreduced digest (P1-P5 in Fig. 3A) that were affected by
reduction indicating that they contained disulfide-linked peptides.
Several peaks appeared in the chromatogram of the reduced peptic digest
that apparently corresponded to cysteine-containing peptides released
from disulfide linkage by reduction. Peaks P1-P5 from the nonreduced
digest were isolated by RP-HPLC of the nonreduced peptic digest for
further analysis to determine the disulfide linkages in HN.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
Chromatographic identification of
disulfide-linked peptic peptides of NDV HN. A,
chromatographic separation of ~21 µg of peptic digest of NDV HN
using a Vydac C18 column (2.1-mm inner diameter × 250 mm). B, chromatogram obtained with the same amount of NDV HN
peptic digest after reduction with tributylphosphine. The separation
conditions were the same as in A. Major peaks affected by
reduction are indicated by P1-P5 in A. Upward
arrows in B indicate peaks that appear as a result of
reduction.
|
|
Overview of Disulfide Linkage Determination--
The strategy for
determination of the disulfide linkages of HN was to use MALDI-TOF-MS
as the primary tool to analyze disulfide-linked peptic peptides in
peaks P1-P5. In cases where this did not produce conclusive results,
peptides were subjected to further treatment(s) involving
deglycosylation and/or additional peptide bond cleavages. Peptides
subjected to these supplementary treatments were also analyzed by
MALDI-TOF-MS and, where necessary, ESI-MS/MS. The simplest cases,
peptic peptides containing single inter- or intrachain disulfides,
generally only required MALDI-TOF-MS to identify the cysteine residues
involved in linkage of the chains. This usually involved analysis of
the constituents of the relevant peak before and after reduction with
TCEP and rationalization of mass changes that accompanied reduction
with reference to cysteine-containing segments of the HN ectodomain
sequence (Fig. 2A). In some cases this alignment process was
aided by the presence of sequence tags originating from ragged peptic
cleavage(s) of the linked chain(s). PSD analysis was also used to
identify reduced chains. In the more complex cases, with peptides
containing both intra- and interchain disulfides, MALDI-TOF-MS usually
enabled identification of the linked chains; however, secondary peptide
bond cleavage(s) was required to convert the intrachain bond into an
interchain bond. When this conversion process produced peptides with
single disulfide linkages it was possible to make disulfide bond
assignments based on MALDI-TOF-MS analyses. When the conversion process
produced peptides with three linked chains ESI-MS/MS provided the means of making the linkage assignments. Using this strategy it was possible
to determine that Cys123 is the residue involved in
homodimerization of NDV ectodomains and to establish
Cys172/Cys196,
Cys186/Cys247,
Cys238/Cys251,
Cys344/Cys461,
Cys455/Cys465, and
Cys531/Cys542 linkages (Fig. 2A).
Data enabling these assignments are presented in Figs.
4 and 5,
supplemental Figs. S2-S6, and Tables I-III. More detailed description
of the data from the analysis of peaks P1-P5 is presented below.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 4.
ESI-MS/MS spectra of the
peptide
Tyr340-Asp349/Cys461-Val469/Phe447-Arg460.
This peptide was derived by treatment of RP-HPLC peak P1 (Fig. 3)
with PNGase F and trypsin and isolated by RP-HPLC as described in Fig.
3. A, ESI-MS/MS of the triply charged ion
(m/z = 1185.0) using a collision energy of 60 eV and
nitrogen as the collision gas. A series of peptide fragments
corresponding to internal cleavages in the
Tyr340-Asp349 chain is indicated. B,
an expansion to show y series fragments between Cys461 and
Cys465. C, the assignment of fragments and
theoretical m/z values. Fragments are defined using standard
nomenclature (53, 54). Average masses are used throughout and take into
account the conversion of Asn341 to Asp as a result of
deglycosylation.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 5.
MALDI-TOF-MS of RP-HPLC peak P2 (Fig.
3). A, nonreduced peak P2 (100 laser shots). Dotted
brackets indicate different forms of peptides containing the same
disulfide linkage(s). B, after reduction with TCEP (125 laser shots). TCEP reduction and MALDI-TOF-MS were performed as
described under "Experimental Procedures." Sequence tags resulting
from ragged cleavage with pepsin are indicated in one-lettered code.
Refer to Table I for identity of peptides.
|
|
Analysis of Peak P1--
A series of ions was observed in
MALDI-TOF-MS spectra of nonreduced peak P1 (Fig. 3A) at
around m/z = 5790 that were separated by approximately
203 and 146 Da (Fig. S2A) suggesting the attachment of a
glycan. These ions disappeared upon reduction and there was a
concomitant appearance of an intense ion at m/z = 2337.1 that corresponded to Phe447-Val469
containing cysteines 455, 461, and 465 in the reduced state (Fig. S2,
A and B and Table
I). This was confirmed by analysis of
fragments formed by PSD of the ion at m/z = 2337.1, which produced data consistent with the sequence
Phe447-Val469 (Table I). An ion at
m/z = 2335.5 also disappeared upon reduction but ions
at m/z = 2078.6 and m/z = 2108.4 were
not affected by reduction (cf. Fig. S2, A and
B). Minor ions at m/z = 2190.0 and m/z = 2238.0 also appeared upon reduction (Fig.
S2B) that corresponded to
Thr448-Val469 and
Phe447-Gly468, respectively, produced by ragged
cleavage (Fig. S2B and Table I). These data indicate that
Phe447-Val469 is linked to a
cysteine-containing glycopeptide. The ion at m/z = 2335.5 in the nonreduced peak may have been due to MALDI-induced cleavage of the interchain disulfide bond of this glycopeptide without
reduction of the intrachain disulfide. The presence of glycosylation
was confirmed by treatment of peak P1 with PNGase F (Table
II), which resulted in appearance of ions
corresponding to Phe447-Val469 linked via a
disulfide to various lengths of peptide sequence containing
Cys344 (Fig. S2C and Table II). The
deglycosylated peptide was treated further with trypsin and analyzed by
liquid chromatography-MS, which showed the presence of a predominant
ion corresponding to Tyr340-Asp349/Cys461-Val469/Phe447-Arg460.
MALDI-TOF-MS of the equivalent fraction isolated by RP-HPLC revealed a
series of ions consistent with this
Cys344/(Cys461,Cys465)/Cys455
arrangement (Fig. S2D and Table II). One round of manual
Edman degradation on this isolated peptide followed by analysis of the product by MALDI-TOF-MS showed the presence of an ion of
m/z = 2103.2 (Fig. S2E and Table II) that
corresponded to
Thr448-Arg460/Pro462-Val469,
thus, establishing a Cys455/Cys465 linkage.
This was complemented by an ion at m/z = 2250.2 that corresponded to
Phe447-Arg460/Pro462-Val469,
which may have been present due to incomplete coupling of
phenylisothiocyanate to Phe447 during the single round of
Edman degradation. This linkage arrangement was also indicated from
liquid chromatography-MS experiments performed on the tryptic peptide
with an elevated ion source orifice potential of 80 V to induce
in-source fragmentation. Under these conditions, an ion was observed at
m/z = 1126.2 that was rationalized in terms of a y-type
cleavage between Cys461 and Pro462 to produce a
fragment containing the Cys455/Cys465 linkage
(Fig. 4C). This observation was corroborated by fragment ions formed during ESI-MS/MS of the deglycosylated tryptic peptide isolated by RP-HPLC,
Tyr340-Asp349/Cys461-Val469/Phe447-Arg460.
A series of doubly charged y-type fragment ions was observed (Fig. 4,
A and B), including the ion at
m/z = 1126.2 (Fig. 4B), corresponding to
cleavages between Cys461 and Cys465 in the
Cys461-Val469 chain (Fig. 4C), which
confirmed the Cys455/Cys465 and
Cys344/Cys461 linkages. Theoretical fragments
that would result from the alternate linkages were not observed in this
spectrum.
View this table:
[in this window]
[in a new window]
|
Table I
Assignment of disulfide-linked peptides in a peptic digest of NDV HN
Pseudomolecular weight data obtained by MALDI-TOF-MS for the major
disulfide-containing peptides isolated from a peptic digest by RP-HPLC
(see Fig. 3) before and after reduction with TCEP.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Data arising from treatment of peak P1
Pseudomolecular weight data obtained by MALDI-TOF-MS for peptic
peptides contained in peak P1 (Fig. 3) after various enzymatic
treatments. Theoretical masses take into account the conversion of
Asn341 to Asp as a result of treatment with PNGase F.
|
|
Analysis of Peaks P2-P4--
MALDI-TOF-MS of peak P2 confirmed
the expectation that individual RP-HPLC peaks would contain multiple
peptide species (Fig. 5A). Pseudomolecular ions were
observed in this peak that could be rationalized as different forms of
three separate species of disulfide-linked peptides. The ion at
m/z = 3033.0 corresponded to the peptide
Ile163-Phe178/Ser194-Tyr205
representing a Cys172/Cys196 linkage. This
assignment was based on the observation of an ion at
m/z = 1622.8 in the reduced digest (Fig. 5B)
that corresponded to Ile163-Phe178 containing
Cys172 (Table I), which could be complemented with the
theoretical mass of Ser194-Tyr205 (1412.6 Da;
not observed) to produce the ion at m/z = 3033.3. This
Cys172/Cys196 linkage could also be deduced
based on data from peak P4 (Fig. S3 and Table I). Ions were observed at
m/z = 3245.9 and 3194.9 in the nonreduced digest (Fig.
S3A and Table I) and at 1622.7 and 1998.7 in the reduced
digest (Fig. S3B and Table I) that corresponded to peptides
linked in this manner (Fig. S3B and Table I).
Ions at m/z = 3746.1, 3675.0, and 3604.1 in nonreduced
peak P2 (Fig. 5A) appeared to be derived from the N terminus
based on the correspondence of the mass differences between these ions with a sequence tag of
Ala117-Ala118-Ser119 that
represents the ragged N terminus of the protein observed by Edman
degradation sequencing of the protein before pepsin digestion. Ions
(m/z = 2202.0, 2130.9, and 2059.9) representing the
same sequence tag were observed in the reduced digest (Fig.
5B). An ion corresponding to the difference between the
reduced and nonreduced sequence tag ions (m/z = 1547.6)
and encompassing the sequence Ala117-Tyr132 was
also observed in the reduced digest (Fig. 5B). The data were assigned to represent homodimerization of the protein via a
Cys123/Cys123 disulfide bond in the form of
peptides
Ala117-Glu139/Ala117-Tyr132,
Ala118-Glu139/Ala117-Tyr132,
and
Ser119-Glu139/Ala117-Tyr132
(Table I).
Ions were also observed in peaks P2 and P4 (Figs. 5 and S3)
corresponding to a
Cys186/(Cys238,Cys247,Cys251/)
arrangement (Table I). Sequence tag information was evident in spectra
of these peaks under both nonreduced and reduced conditions indicating
the presence of peptides containing these cysteines (Table I). This
Cys186/(Cys238,Cys247,Cys251/)
arrangement could form in three alternate ways. Digestion of peak P4,
which contained predominantly
Cys186/(Cys238,Cys247,Cys251/)
peptides (Table I), with chymotrypsin resulted in ions at m/z = 1172.4 and m/z = 2384.9 corresponding to
Cys186-Asn190/Gly246-Leu250
and
Asp230-Leu245/Cys251-Glu256,
respectively (Table III). Reduction of
the chymotryptic digest yielded ions consistent with these assignments
(Table III). Together these data are evidence for
Cys186/Cys247 and
Cys238/Cys251 linkages. Cyanogen bromide
cleavage of
Cys186/(Cys238,Cys247,Cys247/)
peptides in peak P4 resulted in the appearance of ions in the unfractionated cleavage mixture consistent with
Cys186/Cys238 or
Cys186/Cys247 linkages (Table III). The peptide
Met180-Asn190/Asp230-X249/Leu250-Glu256,
where X represents a homoserine lactone residue formed by treatment with cyanogen bromide, was analyzed by ESI-MS/MS (Fig. S4, A
and B). Collisional-induced fragmentation was evident in all
three of the disulfide-linked chains. In particular, a series of doubly and triply charged b- and y-type fragment ions were observed that corresponded to cleavage of peptides bonds between Cys238
and Cys247. Significantly, prominent y-type fragmentation
on the N-terminal side of Pro244 was observed giving rise
to doubly (m/z = 957.0) and triply (m/z = 638.2) charged ions. These ions were complemented by the doubly (m/z = 1136.2) and triply (m/z = 757.7)
charged b-type ions produced by fragmentation of the same peptide bond.
These data were also consistent with the linkages
Cys186/Cys247 and
Cys238/Cys251. Theoretical fragments that would
be produced from alternative disulfide-linked versions of this peptide
were not observed.
View this table:
[in this window]
[in a new window]
|
Table III
Data arising from treatment of peak P4
Pseudomolecular weight data obtained by MALDI-TOF-MS for peptic
peptides contained in peak P4 (Fig. 3) after enzymatic or chemical
treatment.
|
|
The MALDI-TOF-MS spectra obtained for peak P3 before and after TCEP
reduction contained ions consistent with the presence of peptides
representing
Cys186/(Cys238,Cys247,Cys251/)
and Cys172/Cys186 linkages (Table I).
These ions were similar to those detected in peak P4 but with different
relative intensities (Fig. S5), presumably the result of incomplete
chromatographic separation of peptides contained in peaks P3 and P4.
Analysis of Peak P5--
Peak P5 produced a predominant ion at
m/z = 2206.1 and minor associated sequence tag ions
that corresponded to a Cys531/Cys542 linkage
within Thr527-Ala546 and minor forms of the
sequence lacking N-terminal threonine residues (Fig. S6A).
This assignment was corroborated by an increase in mass of these ions
upon reduction (Fig. S6B) and partial sequencing of the
peptide by PSD analysis (Table I). Characterization of this peptide
served to establish that the consensus glycosylation site at
Asn538 was not occupied by a glycan.
 |
DISCUSSION |
Although HN primary sequences have been known for various members
of the paramyxoviridae family of viruses for some time
(41-43), there has been relatively little direct chemical analysis of
the post-translational modifications that accompany maturation of these
proteins into functionally active forms. Exceptions to this are
documentation of the proteolytic activation and N-terminal acetylation
of the HN proteins of some avirulent strains of NDV (44). Documentation
of the disulfide arrangement of the NDV HN in the current study has
provided further insights into the maturation of this protein.
It was possible to unambiguously assign
Cys123/Cys123,
Cys172/Cys196, and
Cys531/Cys542 disulfide linkages by isolation
of peptic peptides of NDV HN containing these linkages and using the
established approach of determination of mass changes caused by
reduction (45, 46). Pepsin was chosen as the primary protease for these
studies as it has a low pH optimum, which makes it ideal for disulfide
identification because of the lower possibility of disulfide exchange
at acid pH (47). Peptic cleavage of HN resulted in complex mixtures of
peptides because of relatively random cleavage at adjacent sites. This
was a potential complication in aligning mass data with the known
sequence of the protein; however, ragged peptic cleavage produced
sequence tags that aided unambiguous alignment of mass data to the
correct portion of the HN sequence.
Assignment of the disulfide linkages within the
Cys344/(Cys455, Cys461,
Cys465/) and
Cys186/(Cys238,Cys247,Cys251/)
clusters was not straightforward as they were contained in two peptides
each of which contained four cysteine residues. The topology of these
two peptides was the same with two chains linked by a single interchain
disulfide linkage and one chain having an additional intrachain
disulfide linkage. With this topology three possible disulfide linkages
are possible. In both cases, determination of the linkages was achieved
by additional peptide bond cleavages between the intrachain disulfides
and subsequent MS/MS of the resultant three chain peptides.
It was of interest to note the different apparent efficiencies of the
proline-directed MS/MS cleavages in the two examples where this was
used to establish or confirm disulfide linkages. In the
Cys344/Cys461,Cys465/Cys455
case, the intensity of the y ion produced as a result of N-terminal proline-directed cleavage between Cys461 and
Pro462 was considerably weaker than for ions produced by
proline-directed cleavage in the other two chains that constituted this
peptide, most notably between Cys344 and Pro345
(Fig. 4). The proline-directed cleavage between Cys461 and
Pro462 appears to be even weaker than fragmentation at
nonproline peptide bonds of the other two chains. In contrast,
proline-directed cleavage between Cys238 and
Cys247, in the
Cys186/Cys247,Cys238/Cys251
peptide, was much more pronounced than at other peptide bonds in the
three chains of this peptide (Fig. S4). The relative difference in
susceptibilities of the cleavages at proline residues between intrachain cysteine residues in these peptides may be because of the
greater distance between Cys238 and Cys247
compared with Cys461 and Cys465. Alternatively,
the fact that Cys461 is in linkage with Pro462
may have constrained proline-directed cleavage; however, this did not
appear to limit cleavage between Cys344 and
Pro345 (Fig. 4). It has been noted previously that peptide
bonds within intrachain cystine loops are resistant to MS/MS cleavage
conditions (48-51). One interpretation is that this is due to steric
constraints induced by the intrachain loop. The present data suggest
that close juxtaposition of two cysteine residues in one peptide
involved in interchain disulfide bonds with two other peptide chains
may also serve to limit cleavage between the intrachain cysteines.
The experimentally determined disulfide linkages are summarized in Fig.
2. During the course of analyzing the peptic profile of HN many minor
disulfide linked peptides were observed that served to corroborate the
disulfide linkages ascertained for the major peaks P1-P5. No peptic
peptides were observed reflecting alternative disulfide linkages. Thus,
although it is not entirely possible to rule out the presence of
alternate disulfide linkages, such linkages would be quantitatively
minor based on assessment of the peptide peak heights from the RP-HPLC profile.
With the exception of Cys123, the remaining cysteine
residues in the ectodomain of the NDV HN are conserved in various
strains of the virus (28, Swiss-Prot release 38). Variation of
Cys123 to Trp has been shown to be functionally acceptable
but it abolishes covalent dimerization in the ectodomain (30-32). The
data presented herein formally confirm that Cys123
participates in covalent dimerization of NDV HN. Alignment of several
paramyxoviridae HN sequences has revealed that most cysteine residues are highly conserved within this family (3, 4, 26). For
example, the analogues of Cys172, Cys196,
Cys238, Cys251, Cys344,
Cys455, Cys461, Cys465,
Cys531, and Cys542 are all invariant in simian
virus 5, Sendai virus, mumps virus, and human parainfluenza viruses 1, 2, and 3. This high degree of evolutionary conservation also suggests
that these disulfides are likely to be important determinants of the
fold and function of the HN protein. The analogues of
Cys186 and Cys247 are only found in simian
virus 5 and human parainfluenza virus 2 but are found in concert
suggesting that they are likely to be in linkage (26). Site-directed
mutagenesis of cysteine residues and probing with conformationally
sensitive antibodies have suggested possible
Cys172/Cys196 and
Cys531/Cys542 linkages and linkages within the
Cys186/(Cys238,Cys247,Cys251/)
and
Cys344/(Cys455,Cys461,Cys465/)
clusters (31). An extension of this work (52) provided evidence that
Cys531/Cys542 linkage may prevent glycosylation
occurring at the intervening consensus site at Asn538. The
experimentally determined disulfide bonding pattern in the present
study confirms the suggestions arising from these alignment and
mutagenesis studies, elucidates the exact linkages in the Cys186/(Cys238,Cys247,Cys251/)
and
Cys344/(Cys455,Cys461,Cys465/)
clusters, and confirms that a consensus site for N-linked
glycosylation at Asn538 was not occupied (52).
The present results also impact on disulfide assignments made based on
the proposed three-dimensional models of the paramyxoviridae HN. In the model of Epa (27), it was considered that
Cys172/Cys196 and
Cys531/Cys542 disulfide linkages were
structurally feasible as previously predicted by Colman et
al. (26) and as confirmed by our results. Colman et al.
(26) had also predicted the Cys186/Cys247
linkage based on their co-existence in NDV, simian virus 5, and parainfluenza virus 2 HN sequences. However, in the model of Epa (27)
these two residues were considered to be too distant for linkage to be
feasible although some uncertainty in the alignment of the model was
noted in this region. The results of the present study clearly confirm
the original prediction regarding this linkage (26) and indicate the
need for further refinement of the subsequent model (27). The model of
Langedijk et al. (9) predicted linkage Cys172/Cys196,
Cys186/Cys247,
Cys238/Cys251, and
Cys531/Cys542 linkages, in accord with our
experimentally determined linkages, but their prediction of
Cys344/Cys465 and
Cys455/Cys461 linkages was incorrect.
The experimentally determined disulfide linkages of the NDV HN protein
are shown in Fig. 2B mapped onto a depiction of the model of
Langedijk et al. (9). Our data are generally consistent with
the model of Langedijk et al. (9) in structural terms. For
example, the Cys531/Cys542 linkage is
consistent with the prediction that these residues are in close
proximity on adjacent strands in the 6 sheet. The flexible loop
regions of the model contain three of the experimentally determined
disulfide linkages (Cys172/Cys196,
Cys344/Cys461, and
Cys455/Cys465) indicating broad compatibility
of the model with our data even though their predictions regarding
linkages within the Cys344/(Cys455,
Cys461, Cys465/) cluster were incorrect.
However, as noted by those authors, Cys455,
Cys461, and Cys465 are predicted to occur in a
long, distended loop region between -sheets 4 and 5 making it
difficult to predict the three-dimensional arrangement of these
residues. The model is also plausible for the
Cys186/Cys247 linkage, which is predicted to
occur between the second strand of the 1 sheet and the flexible loop
connecting strands 1 and 2 of the 2 sheet. Less plausible is the
mapping of the Cys238/Cys251 linkage, which
would appear to place these two residues at some distance. The model of
Epa (27) is similar to that of Langedijk et al. (9) in how
the experimentally determined disulfide linkages map onto the fold of
the protein, the major differences being that the Cys238
and Cys251 residues are now in a more plausible
juxtaposition for linkage but, as noted above, Cys186 and
Cys247 are in a less feasible juxtaposition. Thus, whereas
both models are broadly compatible with our experimentally determined
disulfide linkages, some refinement of both models is required. The
present study highlights the importance of direct determination of
disulfide bond linkage as a means of evaluating theoretically predicted models of protein folding and indicate that determination of the three-dimensional structure of an HN will be required to provide the
refined structural detail. Given the high degree of conservation of
cysteine residues in the rublavirus and
paramyxovirus HN sequences, there is every reason to expect
that the HN of other viruses in this family should have the same
arrangement of disulfide bonds as determined in the present study.
Based on the predicted HN structure, Langedijk et al. (9)
extended their modeling studies to the H of the morbillivirus genus and
concluded that the H also folds into a -sheet propeller structure
(9). They further predicted the existence of a sialidase active site in
H and produced limited data for a highly specific sialidase activity
associated with the morbilliviruses, rinderpest virus, and peste des
petits ruminants virus. Given the errors and some uncertainty regarding
rationalization of the HN disulfide arrangement in terms of their
predicted structure, it would be informative to determine whether their
predicted disulfides in H are correct.
 |
ACKNOWLEDGEMENTS |
We thank Greg Neumann and Phillip Strike for
assistance with ESI-MS/MS and automated Edman degradation sequencing,
respectively. The avirulent strain of NDV used in this study was
prepared by Dennis Grix of the Victorian Institute of Animal Science,
Attwood, Victoria, Australia. Critical review of this manuscript by
Michael Lawrence and Neil McKern is appreciated. The participation of James Pitt in this study was made possible by generous provision of
study leave from the Royal Children's Hospital, Parkville, Victoria, Australia.
 |
FOOTNOTES |
*
This work was presented in part at the XIth International
Congress of Virology, Sydney, Australia, August 9-13, 1999.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The on-line version of this article (available at
http://www.jbc.org) contains supplemental material including
mass spectra presented in Figs. S1-S6.
To whom correspondence should be addressed: Biomolecular Research
Institute, 343 Royal Parade, Parkville, VIC 3052, Australia. Tel.:
61-3-9662-7100; Fax: 61-3-9662-7301; E-mail: jeff.gorman@bioresi. com.au.
 |
ABBREVIATIONS |
The abbreviations used are:
NDV, Newcastle
disease virus;
HN, hemagglutinin neuraminidase glycoprotein;
H, hemagglutinin;
PNGase F, peptide-N-glycosidase F;
TCEP, tris(2-carboxyethyl)phosphine;
MUNANA, 2'-(4-methylumbelliferyl)- -D-N-acetyl-neuraminic
acid;
RP-HPLC, reverse-phase high performance liquid
chromatography;
HNE, HEPES-NaCl-EDTA;
PAGE, polyacrylamide gel
electrophoresis;
MALDI-TOF-MS, matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry;
PSD, post-source decay;
ESI, electrospray ionization;
ESI-MS, electrospray
ionization-mass spectrometry;
MS/MS, tandem mass spectrometry.
 |
REFERENCES |
| 1.
|
Lamb, R. A.,
and Kolakofsky, D.
(1996)
in
Fundamental Virology
(Fields, B. N.
, Knipe, D. M.
, and Howley, P. M., eds)
, pp. 577-604, Lippincott-Raven, Philadelphia
|
| 2.
|
Emmerson, P. T.
(1994)
in
Encyclopedia of Virology
(Webster, R. G.
, and Granoff, A., eds)
, pp. 914-919, Academic Press, London
|
| 3.
|
Morrison, T.,
and Portner, A.
(1991)
in
The Paramyxoviruses
(Kingsbury, D. W., ed)
, pp. 347-382, Plenum Press, New York
|
| 4.
|
Morrison, T.
(1988)
Virus Res.
10,
113-136[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Morrison, T.,
and McQuain, C.
(1991)
J. Virol.
65,
813-822[Abstract/Free Full Text]
|
| 6.
|
Iorio, R. M.,
Glickman, R. L.,
and Sheehan, J. P.
(1992)
J. Gen. Virol.
73,
1167-1176[Abstract/Free Full Text]
|
| 7.
|
Deng, R.,
Wang, Z.,
Glickman, R. L.,
and Iorio, R. M.
(1994)
Virology
204,
17-26[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Deng, R.,
Wang, Z.,
Mirza, A. M.,
and Iorio, R. M.
(1995)
Virology
209,
457-469[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Langedijk, J. P. M.,
Daus, F. J.,
and van Oirschot, J. T.
(1997)
J. Virol.
71,
6155-6167[Abstract]
|
| 10.
|
Markwell, M. K.
(1991)
in
The Paramyxoviruses
(Kingsbury, D. W., ed)
, pp. 407-426, Plenum Press, New York
|
| 11.
|
Berthiaume, L.,
Joncas, J.,
and Pavilanis, V.
(1974)
Arch. Gesamte Virusforsch.
45,
39-51[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Ling, R.,
and Pringle, C. R.
(1989)
J. Gen. Virol.
70,
1441-1452[Abstract/Free Full Text]
|
| 13.
|
Kingsbury, D. W.,
Bratt, M. A.,
Choppin, P. W.,
Hanson, R. P.,
Hosaka, Y.,
ter Meulen, V.,
Norrby, E.,
Plowright, W.,
Rott, R.,
and Wunner, W. H.
(1978)
Intervirology
10,
137-152[Medline]
[Order article via Infotrieve]
|
| 14.
|
Richman, A. V.,
Pedeira, F. A.,
and Tauraso, N. M.
(1971)
App. Microbiol.
21,
1099-1100
|
| 15.
|
Sullender, W. M.,
and Wertz, G. W.
(1991)
in
The Paramyxoviruses
(Kingsbury, D. W., ed)
, pp. 383-406, Plenum Press, New York
|
| 16.
|
Lamb, R. A.
(1989)
in
The Influenza Viruses
(Krug, R. M., ed)
, pp. 1-88, Plenum Press, New York
|
| 17.
|
Wharton, S. A.,
Weis, W.,
Skehel, J. J.,
and Wiley, D. C.
(1989)
in
The Influenza Viruses
(Krug, R. M., ed)
, pp. 153-174, Plenum Press, New York
|
| 18.
|
Colman, P. M.
(1989)
in
The Influenza Viruses
(Krug, R. M., ed)
, pp. 175-218, Plenum Press, New York
|
| 19.
|
Colman, P. M.,
Varghese, J. N.,
and Laver, W. G.
(1983)
Nature
303,
41-44[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Varghese, J. N.,
Laver, W. G.,
and Colman, P. M.
(1983)
Nature
303,
35-40[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Varghese, J. N.,
and Colman, P. M.
(1991)
J. Mol. Biol.
221,
473-486[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Tulip, W. R.,
Varghese, J. N.,
Baker, A. T.,
van Donkelaar, A.,
Laver, W. G.,
Webster, R. G.,
and Colman, P. M.
(1991)
J. Mol. Biol.
221,
487-497[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Baker, A. T.,
Varghese, J. N.,
Laver, W. G.,
Air, G. M.,
and Colman, P. M.
(1987)
Proteins Struct. Funct. Genet.
2,
111-117[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Burmeister, W. P.,
Ruigrok, R. W. H.,
and Cusack, S.
(1992)
EMBO J.
11,
49-56[Medline]
[Order article via Infotrieve]
|
| 25.
|
Jorgensen, E. D.,
Collins, P. L.,
and Lomedico, P.
(1987)
Virology
156,
12-24[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Colman, P. M.,
Hoyne, P. A.,
and Lawrence, M. C.
(1993)
J. Virol.
67,
2972-2980[Abstract/Free Full Text]
|
| 27.
|
Epa, V.
(1997)
Proteins Struct. Funct. Genet.
29,
264-281[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Sakaguchi, T.,
Toyoda, T.,
Gotoh, B.,
Inocencio, N. M.,
Kuma, K.,
Miyata, T.,
and Nagai, Y.
(1989)
Virology
169,
260-272[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Collins, P. L.,
and Mottet, G.
(1991)
J. Virol.
65,
2362-2371[Abstract/Free Full Text]
|
| 30.
|
Sheehan, J. P.,
Iorio, R. M.,
Sydall, R. J.,
Glickman, R. L.,
and Bratt, M. A.
(1987)
Virology
161,
603-606[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
McInnes, L. W.,
and Morrison, T.
(1994)
Virology
200,
470-483[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Mirza, A. M.,
Sheehan, J. P.,
Hardy, L. W.,
Glickman, R. L.,
and Iorio, R. M.
(1993)
J. Biol. Chem.
268,
21425-21431[Abstract/Free Full Text]
|
| 33.
|
Thompsom, S. D.,
Laver, W. G.,
Murti, K. G.,
and Portner, A.
(1988)
J. Virol.
62,
4653-4660[Abstract/Free Full Text]
|
| 34.
|
Ng, D. T. W.,
Randall, R. E.,
and Lamb, R. A.
(1989)
J. Cell Biol.
109,
3273-3289[Abstract/Free Full Text]
|
| 35.
|
Hodder, A. N.,
Selleck, P. W.,
White, J. R.,
and Gorman, J. J.
(1993)
J. Gen. Virol.
74,
1081-1091[Abstract/Free Full Text]
|
| 36.
|
Hodder, A. N.,
Liu, Z. Y.,
Selleck, P. W.,
Corino, G. L.,
Shiell, B. J.,
Grix, D. C.,
Morrow, C. J.,
and Gorman, J. J.
(1994)
Avian Dis.
38,
103-118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Gorman, J. J.,
Ferguson, B. L.,
and Nguyen, T. B.
(1996)
Rapid Commun. Mass Spectrom.
10,
529-536[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Rouse, J. C., Yu, W.,
and Martin, S. A.
(1995)
J. Am. Soc. Mass Spectrom.
6,
822-835[CrossRef]
|
| 40.
|
Vorm, O.,
Roepstorff, P.,
and Mann, M.
(1994)
Anal. Chem.
66,
3281-3287[CrossRef]
|
| 41.
|
Blumberg, B. M.,
Giorgi, C.,
Roux, L.,
Raju, R.,
Dowling, P.,
Chollet, A.,
and Kolakofsky, D.
(1985)
Cell
41,
269-278[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Hiebert, S.,
Paterson, R. G.,
and Lamb, R. A.
(1985)
J. Virol.
54,
1-6[Abstract/Free Full Text]
|
| 43.
|
Miura, N.,
Nakatani, Y.,
Ishiura, M.,
Uchida, T.,
and Okada, Y.
(1985)
FEBS Lett.
188,
112-116[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Gorman, J. J.,
Nestorowicz, A.,
Mitchell, S. J.,
Corino, G. L.,
and Selleck, P. W.
(1988)
J. Biol. Chem.
263,
12522-12531[Abstract/Free Full Text]
|
| 45.
|
Yazdanparast, R.,
Andrews, P.,
Smith, D. L.,
and Dixon, J. E.
(1986)
Anal. Biochem.
153,
348-353[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Yazdanparast, R.,
Andrews, P.,
Smith, D. L.,
and Dixon, J. E.
(1987)
J. Biol. Chem.
262,
2507-2513[Abstract/Free Full Text]
|
| 47.
|
Smyth, D. G.
(1967)
Methods Enzymol.
11,
214-231[CrossRef]
|
| 48.
|
Bean, M. F.,
and Carr, S. A.
(1992)
Anal. Biochem.
201,
216-226[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Katta, V.,
Liu, N.,
Meng, S.,
Zamborelli, T.,
Mayer, J.,
Lu, H.,
and Hara, S.
(1995)
Proc. Am. Soc. Mass Spectrom. Conf. Mass Spectrom. Allied Top.
43,
1277
|
| 50.
|
Suckau, D.,
Holle, A.,
and Resemann, A.
(1996)
Proc. Am. Soc. Mass Spectrom. Conf. Mass Spectrom. Allied Top.
44,
1339
|
| 51.
|
Gorman, J. J.,
Ferguson, B. L.,
Speelman, D.,
and Mills, J.
(1997)
Protein Sci.
6,
1308-1315[Medline]
[Order article via Infotrieve]
|
| 52.
|
McInnes, L. W.,
and Morrison, T.
(1997)
J. Virol.
71,
3083-3089[Abstract]
|
| 53.
|
Biemann, K.
(1988)
Biomed. Environ. Mass Spectrom.
16,
99[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Roepstorff, P.,
and Fohlman, J.
(1984)
Biomed. Mass Spectrom.
11,
601[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. R. White, V. Boyd, G. S. Crameri, C. J. Duch, R. K. van Laar, L.-F. Wang, and B. T. Eaton
Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus
J. Gen. Virol.,
October 1, 2005;
86(10):
2839 - 2848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Panda, S. Elankumaran, S. Krishnamurthy, Z. Huang, and S. K. Samal
Loss of N-Linked Glycosylation from the Hemagglutinin- Neuraminidase Protein Alters Virulence of Newcastle Disease Virus
J. Virol.,
May 15, 2004;
78(10):
4965 - 4975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Wallis, C.-Y. Huang, S. B. Nimkar, P. R. Young, and J. J. Gorman
Determination of the Disulfide Bond Arrangement of Dengue Virus NS1 Protein
J. Biol. Chem.,
May 14, 2004;
279(20):
20729 - 20741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-M. She, S. Haber, D. L. Seifers, A. Loboda, I. Chernushevich, H. Perreault, W. Ens, and K. G. Standing
Determination of the Complete Amino Acid Sequence for the Coat Protein of Brome Mosaic Virus by Time-of-Flight Mass Spectrometry. EVIDENCE FOR MUTATIONS ASSOCIATED WITH CHANGE OF PROPAGATION HOST
J. Biol. Chem.,
June 1, 2001;
276(23):
20039 - 20047.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|